ENDOTIS
Endotis discovers, develops, and manufactures cardiovascular therapeutics. The company also discovers and develops small-glyco drugs for applications in thrombosis, oncology, and hematology areas. Its portfolio of products includes EP217609, a neutralizable anti-coagulant for managing extracorporeal blood circulation during open-heart surgery; FondaParinux, an injectable drug for the prevention and treatment of venous thromboembolism; and an oral anti-coagulant for stroke prevention in atrial fibrillation. Endotis was founded in 2003 and is based in Romainville, France.
ENDOTIS
Industry:
Biopharma Biotechnology Health Care Manufacturing Therapeutics
Founded:
2003-01-01
Address:
Romainville, Ile-de-France, France
Country:
France
Website Url:
http://www.endotis.com
Total Employee:
1+
Status:
Active
Contact:
33 1 48 46 43 91
Total Funding:
29 M EUR
Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Novolytics
Novolytics is developer of bacteriophage-based therapeutics.
Current Advisors List
Investors List
Wellcome Trust
Wellcome Trust investment in Series B - Endotis
Sofinnova Partners
Sofinnova Partners investment in Series A - Endotis
Official Site Inspections
http://www.endotis.com
- Host name: ec2-18-119-154-66.us-east-2.compute.amazonaws.com
- IP address: 18.119.154.66
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
